^
BIOMARKER:

LMNA-NTRK1 fusion

i
Other names: LMNA, Prelamin-A/C, LMN1, Mandibuloacral dysplasia type A, Limb girdle muscular dystrophy 1B (autosomal dominant), Cardiomyopathy dilated 1A (autosomal dominant), Lamin A/C, FPLD2, LGMD1B, CMT2B1, Renal carcinoma antigen NY-REN-32, Progeria 1 (hutchinson-gilford type), NTRK1, MTC, TRK, TRKA, Neurotrophic tyrosine kinase, receptor, type 1
Entrez ID:
LMNA-NTRK1 fusion
Breast Cancer
larotrectinib
Sensitive: C3 – Early Trials
LMNA-NTRK1 fusion
Soft Tissue Sarcoma
larotrectinib
Sensitive: C4 – Case Studies
LMNA-NTRK1 fusion
Breast Cancer
ceritinib
Sensitive: D – Preclinical